Literature DB >> 20193105

The asymmetric division and tumorigenesis of stem cells.

Qi-Zhao Wang1, Ying-Hui Lu, Nan Jiang, Yong Diao, Rui-An Xu.   

Abstract

Stem cells use asymmetric and symmetric cell division to generate progeny. Symmetric cell division is defined as the generation of daughter cells that are destined to acquire the same fate. Stem cells divide asymmetrically to generate one daughter with a stem-cell fate and one daughter with different fate. Disruption of the machinery that regulates asymmetric division may be a reason for the generation of cancer. The asymmetric mechanism is maintained by cell polarity factors, cell fate determinants, and the spindle apparatus. The mutation or dysregulation of these factors may change stem cells from asymmetric to symmetric cell division, then leading to tumorigenesis. Therefore, further study is needed on the mechanisms of stem cell control between asymmetric and symmetric cell division, as well as the relationships among stem cells, cancer stem cells, and tumor cells. It may bring us a new approach for the resistance, recurrence, and metastasis of tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193105     DOI: 10.5732/cjc.009.10668

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  3 in total

1.  Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis.

Authors:  Yifan Wang; Binhua P Zhou
Journal:  Cancer Hallm       Date:  2013-03

2.  Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.

Authors:  Camila Leonel; Thaiz Ferraz Borin; Lívia de Carvalho Ferreira; Marina Gobbe Moschetta; Marcio Chaim Bajgelman; Alicia M Viloria-Petit; Debora Aparecida Pires de Campos Zuccari
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-01-11       Impact factor: 2.673

Review 3.  Epithelial-mesenchymal transition in breast cancer progression and metastasis.

Authors:  Yifan Wang; Binhua P Zhou
Journal:  Chin J Cancer       Date:  2011-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.